WASHINGTON, DC – Global law firm Reed Smith LLP today announced that James Segroves has joined the firm’s Life Science Health Industry group as partner in the Washington, D.C. office. Segroves brings extensive experience representing clients on a wide array of complex healthcare regulatory and litigation matters, including federal False Claims Act (FCA) cases, government investigations and regulatory disputes.

Profesionales relacionados:: James F. Segroves

“In the face of a regulatory environment where uncertainty and change have become the norm, our clients’ need for legal representation and guidance has never been greater,” said Reed Smith Partner Scot Hasselman, co-chair of the Life Sciences Health Industry group. “James provides the blend of regulatory and litigation experience our clients require. His extensive experience handling large and highly consequential FCA cases in an array of trial and appellate courts makes him a particularly valuable  resource for our clients. We are thrilled that he has joined our team in DC.”

Previously a partner at Hooper, Lundy & Bookman, PC, Segroves is a seasoned litigator, representing hospitals and health systems, post-acute providers, public agencies and industry trade associations in a number of high-profile and precedent-setting cases involving matters of first impression before various appellate courts, state supreme courts and the U.S. Supreme Court. He also has advised clients on key issues under the FCA, the Federal Arbitration Act and the Administrative Procedure Act.